Pear Therapeutics, Inc.

PEAR · NASDAQ
Analyze with AI
12/31/2022
9/30/2022
6/30/2022
3/31/2022
Assets
Cash & Equivalents$48,301$59,685$60,185$89,434
Short-Term Investments$10,971$23,934$46,922$47,967
Receivables$6,943$7,183$5,377$4,131
Inventory$69$74$66$0
Other Curr. Assets$6,675$7,992$8,320$8,519
Total Curr. Assets$72,959$98,868$120,870$150,051
Property Plant & Equip (Net)$14,955$15,810$16,410$16,582
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$7,215$5,057$5,239$5,459
Total NC Assets$22,170$20,867$21,649$22,041
Other Assets$0$0$0$0
Total Assets$95,129$119,735$142,519$172,092
Liabilities
Payables$3,263$1,124$2,040$3,750
Short-Term Debt$29,431$29,345$29,175$28,930
Tax Payable$0$0$0$0
Deferred Revenue$284$482$680$1,020
Other Curr. Liab.$16,464$17,204$15,071$12,679
Total Curr. Liab.$49,442$48,155$46,966$46,379
LT Debt$8,176$8,718$9,217$9,695
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$6,926$10,616$7,296$46,509
Total NC Liab.$15,102$19,334$16,513$56,204
Other Liabilities$0$0$0$0
Cap. Leases$0$0$0$0
Total Liabilities$64,544$67,489$63,479$102,583
Equity
Pref Stock$0$0$0$0
Common Stock$14$14$14$14
Retained Earnings-$323,474-$297,103-$266,380-$271,842
AOCI-$47-$112-$120-$43
Other Equity$354,092$349,447$345,526$341,380
Total Equity$30,585$52,246$79,040$69,509
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$95,129$119,735$142,519$172,092
Net Debt-$10,694-$21,622-$21,793-$50,809